Results 131 to 140 of about 14,544 (270)

Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat

, 2012
Kazunori Takahashi, Hiroki Mizukami, Kosuke Kamata, Wataru Inaba, Noriaki Kato, Chihiro Hibi, Soroku Yagihashi   +6 more
openalex   +2 more sources

Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis

, 2008
Viktor R. Drel, Pál Pacher, Tayyeba K. Ali, Jeho Shin, Ulrich Julius, Azza B. El‐Remessy, Irina G. Obrosova   +6 more
openalex   +2 more sources

Studies on aldose reductase inhibitors from natural products. Part III. Studies on aldose reductase inhibitors from medicinal plant of "Sinfito," Potentilla candicans, and further synthesis of their related compounds.

, 1990
Satoshi Terashima, Mineo Shimizu, Hajime NAKAYAMA, Masatoshi ISHIKURA, Yutaka Ueda, Kunihiro IMAI, Akio Suzui, Naokata Morita   +7 more
openalex   +2 more sources

Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors

, 2007
Anna María Ferrari, Gianluca Degliesposti, Miriam Sgobba, Giulio Rastelli   +3 more
openalex   +2 more sources

Aldose Reductase Inhibitor [PDF]

, 2020
openaire   +1 more source

Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death. [PDF]

, 2019
学位記番号 ...
Shibusawa, Ryo, シブサワ, リョウ, 澁澤, 良   +2 more
core  

In Search of Differential Inhibitors of Aldose Reductase [PDF]

, 2022
Francesco Balestri, Roberta Moschini, Umberto Mura, Mario Cappiello, Antonella Del Corso   +4 more
openalex   +1 more source

Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications

Vascular Health and Risk Management, 2008
Brian C Cumbie, Kathie L HermayerDivision of Endocrinology, Diabetes and Medical Genetics, Medical University of South Carolina, Charleston, South Carolina, USAAbstract: Microvascular complications characterized by retinopathy, nephropathy, and ...
Brian C Cumbie, Kathie L Hermayer
doaj  

General toxicity assessment of the novel aldose reductase inhibitor cemtirestat. [PDF]

Interdiscip Toxicol, 2019
Prnová MŠ, Račková L, Kováčiková L, Balleková J, Viskupičová J, Micháliková S, Taşkoparan B, Elmazoğlu Z, Rižner TL, Karasu C, Banerjee S, Štefek M.   +11 more
europepmc   +1 more source

De novo designing of novel drug-like inhibitors of aldose reductase

, 2023
Priyadarshi Gautam, Priya Bisht, Sant Kumar Verma   +2 more
openalex   +1 more source